A major challenge for distinguishing cancer-causing driver mutations from inconsequential passenger mutations is the long-tail of infrequently mutated genes in cancer genomes. Here, we present and evaluate a method for prioritizing cancer genes accounting not only for mutations in individual genes but also in their neighbors in functional networks, MUFFINN (MUtations For Functional Impact on Network Neighbors). This pathway-centric method shows high sensitivity compared with gene-centric analyses of mutation data. Notably, only a marginal decrease in performance is observed when using 10 % of TCGA patient samples, suggesting the method may potentiate cancer genome projects with small patient populations
<div><p>A major challenge in interpreting the large volume of mutation data identified by next-gener...
Many forms of cancer have multiple subtypes with different causes and clinical outcomes. Somatic tum...
<div><p>Development of high-throughput monitoring technologies enables interrogation of cancer sampl...
A major challenge for distinguishing cancer-causing driver mutations from inconsequential passenger ...
Abstract Background The diversity of genomic alterations in cancer poses challenges to fully underst...
A major goal of cancer sequencing projects is to identify genetic alterations that determine clinica...
Large-scale cancer genomics projects are providing a wealth of somatic mutation data from a large nu...
Abstract Background As one of the deadliest diseases in the world, cancer is driven by a few somatic...
Genomic information on tumors from 50 cancer types cataloged by the International Cancer Genome Cons...
A central goal in cancer genomics is to identify the somatic alterations that underpin tumor initiat...
Cancers exhibit extensive mutational heterogeneity and the resulting long tail phenomenon complicate...
Genome-wide measurements of genomic state offer unprecedented opportunities for biological discovery...
A major challenge in interpreting the large volume of mutation data identified by next-generation se...
Cancers exhibit extensive mutational heterogeneity, and the resulting long-tail phenomenon complicat...
Background: Large-scale cancer genomic projects are providing lots of data on genomic, epigenomic an...
<div><p>A major challenge in interpreting the large volume of mutation data identified by next-gener...
Many forms of cancer have multiple subtypes with different causes and clinical outcomes. Somatic tum...
<div><p>Development of high-throughput monitoring technologies enables interrogation of cancer sampl...
A major challenge for distinguishing cancer-causing driver mutations from inconsequential passenger ...
Abstract Background The diversity of genomic alterations in cancer poses challenges to fully underst...
A major goal of cancer sequencing projects is to identify genetic alterations that determine clinica...
Large-scale cancer genomics projects are providing a wealth of somatic mutation data from a large nu...
Abstract Background As one of the deadliest diseases in the world, cancer is driven by a few somatic...
Genomic information on tumors from 50 cancer types cataloged by the International Cancer Genome Cons...
A central goal in cancer genomics is to identify the somatic alterations that underpin tumor initiat...
Cancers exhibit extensive mutational heterogeneity and the resulting long tail phenomenon complicate...
Genome-wide measurements of genomic state offer unprecedented opportunities for biological discovery...
A major challenge in interpreting the large volume of mutation data identified by next-generation se...
Cancers exhibit extensive mutational heterogeneity, and the resulting long-tail phenomenon complicat...
Background: Large-scale cancer genomic projects are providing lots of data on genomic, epigenomic an...
<div><p>A major challenge in interpreting the large volume of mutation data identified by next-gener...
Many forms of cancer have multiple subtypes with different causes and clinical outcomes. Somatic tum...
<div><p>Development of high-throughput monitoring technologies enables interrogation of cancer sampl...